Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.52+0.02 (+1.33%)
Close on Nov 19, 2026Market cap $72.03MP/E –Yield –
Zhengye Biotechnology pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Zhengye Biotechnology's pe ratio was 21.9× on Feb 27, 2026, against 44.4× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 21.9× | −10.2 |
| 2025 | Dec 31, 2025 | 32.2× | – |
See a number that looks wrong?